US EditionStudy finds hepatitis A vaccination will be cost-effective in Kerala
Summary by sciencechronicle.in
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Study finds hepatitis A vaccination will be cost-effective in Kerala
Cost-effectiveness evidence supports the inclusion of hepatitis A vaccination into the vaccination programme for children aged one year and individuals aged 15 years in Kerala With better sanitation and hygiene, hepatitis A infection in Kerala has been witnessing an epidemiological transition — the infection is shifting from early childhood to adolescents and young adults. The … Continue reading Study finds hepatitis A vaccination will be cost-e…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
